Wire Stories
Harrow Health Acquires Ophthalmic Surgical Drug Candidate From Wakamoto Pharmaceutical Co., Ltd.
NASHVILLE, Tenn. & TOKYO–(BUSINESS WIRE)–$HROW–Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic?focused healthcare company, today announced that it has entered into an agreement...